Analysis Shows Effectiveness of Brensocatib in Adolescents With Bronchiectasis
Recent results from the ASPEN trial indicate that both the 10 mg and 25 mg doses of brensocatib are associated with a lower rate...
Study: Rilzabrutinib Associated With Less Loss of Asthma Control
A new study presented atthe American Thoracic Society 2025 International Conference indicates that rilzabrutinib treatment is associated with fewer loss of asthma control (LOAC)...
Hospitalization, High Costs Common After Bronchiectasis Management
A recent study presented at the American Thoracic Society 2025 International Conference underscores the severity and rapid onset of exacerbations in non-cystic fibrosis bronchiectasis...
ICU Survivors Fall Short of Recommended Activity Levels After Discharge
Survivors of critical illness may need dedicated follow-up as long as six months after hospitalization to regain expected levels of physical activity, according to...